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ABSTRACT 
The microbial community making up the gut microbiota can profoundly influence intestinal 
homeostasis and immune system development, and is believed to influence the development 
of complex diseases including type 1 diabetes (T1D). T1D susceptible non-obese diabetic 
(NOD) mice have been shown to harbour a distinct microbiota to disease protected mice. We 
hypothesised that the T1D susceptible genetic background of NOD mice would be resistant to 
the introduction of a C57BL/6 derived microbiota. NOD and C57BL/6 mice were cohoused 
either continually from birth, from birth until weaning or from weaning onwards, allowing 
transfer of microbiota between the mice. Cohousing NOD with C57BL/6 mice from before 
birth, resulted in moderate changes to the gut microbiota, whereas initiating co-housing at 
weaning only led to minimal changes. Terminating cohousing at weaning reduced the 
changes in the microbiota composition. However, diabetes onset was not significantly 
delayed and there was no reduction in intestinal inflammation or the proportion of regulatory 
T cells in the co-housed NOD mice. However, insulin but not IGRP-specific CD8+ T cells 
were reduced by co-housing suggesting an epitope-specific modulation of the autoreactive 
response by the gut microbiota. These results suggest that the T1D susceptible genetic 
background of the NOD mouse was resistant to the introduction of a C57BL/6 derived 
microbiota.  
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INTRODUCTION 
A number of studies have described alterations in the gut microbiota associated with type 1 
diabetes (T1D) which is thought to be linked to disease pathogenesis 
1-5
. Recently, we have 
shown that genetic susceptibility to T1D contributes to the structure of the intestinal 
microbiota in both T1D susceptible NOD mice and humans 
6
. In NOD mice, manipulations 
that lead to major disturbances in the microbiota can both protect from and accelerate disease 
7-9
. This suggests that a balance between host genetics and environment contributes to 
dysbiosis associated with T1D risk.  
We previously reported low-level intestinal inflammation in NOD compared to disease 
protected mice 
6
. It is unknown the extent to which genetically driven gut inflammation is a 
barrier to therapies designed to restore a healthy microbiota in T1D. In this study, we have 
investigated whether the genetic effect on the NOD microbiota composition could be 
overcome by the introduction of a highly dissimilar microbiota from diabetes-protected mice 
and whether this could reduce intestinal inflammation and disease progression.  
 
METHODS 
 
Mice and Cohousing Design:  
Female mice were housed in specific pathogen free conditions within the University of 
Queensland Biological Resource Facility. All experiments were approved by the University 
of Queensland Animal Ethics committee. NOD/Lt (NOD) and C57BL/6 (B6) mice were from 
the Animal Resources Centre (ARC, Perth, WA, Australia). For experiment 1, NOD mice 
were randomly allocated into two groups; control or cohoused at weaning. The cohoused 
group were caged with age matched B6 mice at a 1:1 ratio. For experiment 2, an adult virgin 
B6 female was cohoused with a pregnant NOD dam until weaning. At weaning, pups were 
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either cohoused with B6 aged matched mice at a 1:1 ratio or housed in single strain cages. 
Diabetes was tested weekly using urine or blood glucose measurement (≥16 mmol/L 
considered diabetic) and confirmed on a second consecutive day. 
 
16s rRNA gene sequencing:  
Faecal pellets were collected from multiple cages to minimise cage effects. Bacterial DNA 
was extracted from faecal pellets and used for 16S rRNA gene sequencing as previously 
described 
10
. Rarefaction was applied at 3150. Communities were visualized with R package 
mix0mics for sparse partial least squares discriminant analysis (sPLS-DA) and for visualizing 
plot loadings 
11
.  
 
Histology:  
Insulitis and intestinal inflammation was scored from sections stained with Hematoxylin and 
eosin or Periodic Acid-Schiff stain and scored as previously described 
6
 
12
. Lysozyme 
staining used antibodies listed in Supplementary Table 1 and 3,3′-diaminobenzidine (DAB). 
Goblet cell abundance was determined using region of interest area of goblet staining 
intensity of each crypt using NIS Elements software (Nikon Instruments, Melville, NY).  
 
Flow cytometry 
Single cell suspensions were prepared from spleen and lymph nodes and red blood cells were 
lysed with ACK buffer. Dead cells were excluded using live-dead stain (Biolegend, San 
Diego, CA). Antibodies are listed in Supplementary Table 1. Foxp3 staining used the Foxp3 
Staining Set (eBioscience). Lymphocytes were stained with PE-conjugated tetramers 
(IGRP206-214-K
d
, Insulin15-23G9V-K
d
 and LLO91-99-K
d
 , NIH tetramer core facility) for 15 
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minutes at room temperature. Samples were run on the FACS LSR Fortessa (BD Bioscience, 
San Jose, CA) and analysed using FlowJo (Tree Star, Ashland, OR). 
 
Statistics 
16s rRNA gene sequencing data were analysed through QIIME (MacQiime 1.9.1) and 
RStudio (Version 1.0.143). Permutation ANOVA, ANOSIM and ADONIS were carried out 
using R scripts with R vegan v2.4-3, limma v3.30.13 and RVAideMemoire v 0.9-64 (Version 
6). Correction for multiple testing used the Benjamini and Hochberg method. Taxa with 
adjusted P-values <0.05 were further investigated with post-hoc Tukey tests performed in 
GraphPad Prism. Level of significance is denoted: *= P-value  < 0.05, **= P-value  < 0.01, 
***= P-value < 0.001, ****= P-value < 0.0001. 
 
RESULTS  
Cohousing NOD and B6 mice from early-life results in modest alterations in the gut 
microbiota.  
We aimed to test whether co-housing T1D susceptible NOD and disease-protected B6 mice 
would result in the NOD microbiota becoming more B6-like and protect from disease. The 
study was split into two experiments (Figure 1a). In the first experiment, NOD pups were 
cohoused with age-matched B6 pups from weaning (CoH@W). In the second experiment, 
NOD mice were cohoused with B6 mice from birth either continually (long-cohoused: 
LCoH) or until weaning (short co-housed: SCoH). Fecal samples were collected at weaning 
and 10-12 weeks of age and used to profile the microbial community composition.  
By 10-12 weeks of age, sPLS-DA multivariate analysis showed that cohousing from weaning 
modestly altered the NOD microbiota (Figure 1b, NOD control vs CoH@W P=0.05). Non-
cohoused NOD and B6 mice had distinct gut microbial communities (P < 0.001, 
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Supplementary Figure 1a). Only two genera (Clostridiaceae and Clostridium) had altered 
abundances in NOD CoH@W compared to control NOD mice (Supplementary Figure 1a), 
but not in the direction of the B6 mice. Consistent with this, the Shannon diversity index was 
not increased by cohousing from weaning (Supplementary Figure 2a). In contrast, both LCoH 
and SCoH NOD mice had a significantly altered microbiota to control NOD mice (Figure 1c, 
P=0.018 and P=0.003 respectively). Eight genera were significantly altered in LCoH 
compared with the control NOD mice (Figure1d), though many other genera were not altered 
(Supplementary Figure 1b). Some taxa that were significantly increased in abundance by 
long-term cohousing were not altered or had a partial increase following short-term 
cohousing (e.g. Parabacteroides, unclassified YS2 and Clostridium). Consistent with this, the 
Shannon diversity index was not increased in SCoH NOD mice but was in the LCoH NOD 
mice (Supplementary Figure 2b). Together, these data suggest that the majority of changes to 
the microbiota were introduced prior to weaning, but the NOD intestinal environment may 
cause the microbiota to revert back to a steady state over time. 
We also compared the microbiota of the cohoused mice at weaning when the LCoH and 
SCoH groups were separated from each other. As expected, while the microbiota profiles of 
cohoused and non-cohoused NOD mice were different at weaning (P = 0.02), the LCoH and 
SCoH groups were not significantly different at the time of separation (Supplementary Figure 
3a). Likewise, the Shannon diversity index was increased at 3 weeks of age in both LCoH 
and SCoH groups compared with the control NOD mice (Supplementary Figure 3b). These 
data indicate that cohousing during the neonatal period is essential for effective transfer of 
bacterial species into the NOD gut, although maintaining co-housing past weaning was 
required to preserve these changes to a maximal effect. 
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Cohousing NOD mice with B6 did not significantly affect the incidence of diabetes. 
We next investigated whether introduction of B6 derived taxa by cohousing impacted the 
onset of diabetes. Cohousing from weaning showed a trend to delaying the progression of 
diabetes (Figure 2a, P=0.056). LCoH NOD mice showed a trend to a reduced frequency of 
diabetes; however, this was not significant (Figure 2b, P =0.244). SCoH NOD mice had a 
similar disease onset to control NOD mice (Figure 2b, P = 0.24). There was also no 
difference in insulitis scores between LCoH and control NOD mice (Figure 2c-d). Thus, the 
changes in the NOD microbiota brought about by cohousing with B6 mice were not sufficient 
to significantly prevent or slow progression to diabetes.  
 
Cohousing did not reduce subclinical intestinal inflammation in NOD mice 
We next questioned whether cohousing had any effect on the subclinical intestinal 
inflammation seen in NOD mice
6
. As expected, control NOD had significantly higher 
inflammation scores compared to B6 mice (Figure 3a). B6 mice had an increased goblet cell 
area (Figure 3b) and Paneth cell staining of lysozyme P in the ileum to NOD mice (Fig 3c). 
However, there were no statistically significant differences between LCoH and control NOD 
mice in inflammatory scoring, goblet cell area or lysozyme P staining. We concluded that the 
altered abundance of the taxa shown in Figure 1d did not impact intestinal inflammation 
present in NOD mice.  
 
Cohousing did not have a significant impact on the frequency of regulatory T cells but 
reduced the frequency of insulin-specific CD8+ T cells 
Regulatory immune T cells (Tregs) play an important role in suppressing autoimmunity and 
defects in Tregs activity, contribute to the development of T1D 
13-15
. Specific members of the 
gut microbiota have been shown to impact peripheral induction of Tregs 
16
. We examined 
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Treg frequencies in the mesenteric, pancreatic and inguinal lymph nodes and spleen. B6 mice 
had significantly higher proportions of CD4+Foxp3+ Tregs in their lymph nodes and 
relatively less in spleen compared with both NOD and LCoH NOD mice as previously 
described (Figure 4a) 
17
. No difference was seen between the proportions of Tregs in LCoH 
and non-cohoused NODs. Islet-specific glucose-6-phosphatase catalytic subunit-related 
protein (IGRP) is a major autoantigen in the NOD mouse 
18
. Several species of the 
Bacteroides genera express an epitope that mimics IGRP and can promote recruitment of 
diabetogenic CD8+ T cells to the gut
19, 20
. We did not observe any differences in the 
frequency of IGRP-specific CD8+ T cells in lymph nodes of NOD and LCoH NOD mice 
using IGRP-specific tetramers (Figure 4b). Strikingly, insulin-specific CD8+ T cells were 
significantly decreased in the pancreatic and mesenteric lymph nodes of LCoH NOD mice 
(Figure 4c). We concluded that while cohousing NOD mice with B6 mice did not have a 
significant effect on peripheral Tregs, autoreactive CD8+ T cells were differentially impacted 
depending on their specificity.  
 
DISCUSSION 
We hypothesised that cohousing NOD and B6 mice would change the gut microbiota of the 
NOD mice to become more B6-like. However, the effects of cohousing were modest and 
terminating cohousing at weaning reduced the effect. Exposure during the pre-weaning 
period was essential for optimal establishment of a new microbiota. The changes induced in 
the gut bacterial communities of the NOD mice were not sufficient to alter either the gut 
inflammatory environment or to prevent diabetes development. Notably, insulin but not 
IGRP-specific CD8+ T cells were modulated by co-housing suggesting that the microbiota 
influence autoreactive T cells in an epitope-specific manner.   
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In our colony, the B6 mice had a microbiota dominated by Allobaculum while the NOD mice 
had a predominance of Lactobacillus. Surprisingly, neither cohousing from before birth or 
from weaning changed the abundance of these genera. The taxa that were altered were all 
obligate anaerobes, which might infer that cohousing leads to a less oxidative intestinal 
environment. An aerobic intestinal environment has been associated with dysbiosis and 
disease 
21
. However, intestinal inflammation observed histologically in NOD mice was not 
reduced by cohousing. 
Introduction of a new microbiota into NOD mice may be dependent on the specific strain and 
sex of the donor. For example, cross-fostering NOD pups to non-obese resistant (NOR) 
mothers permanently altered the microbiota of the offspring
22
. However, this only resulted in 
a significant reduction in diabetes in the male offspring. An adult male NOD microbiota 
transferred to females by oral gavage was able to protect from diabetes and alter the 
recipient's microbiota 
23
. Others have reported that B6 foster parents did not transfer diabetes 
protection to NOD mice, whereas ICR foster parents did 
24
. It is therefore likely that the 
microbiota composition of the donor strain is critical for determining protection. 
The small effects on the NOD microbiota may be because of passive microbiota transfer 
through cohousing. While we introduced the B6 and their microbiota, we did not cross foster 
the NOD pups onto B6 dams. This would have allowed closer interaction between the NOD 
pups and the B6 females as well as exposing them to maternal antibodies from the B6 
mothers. Maternal antibodies contribute to shaping the microbiota of the offspring 
25
. 
The small changes in the microbiota we observed may have been due to an inherent 
incompatibility for one another’s microbiota due to genetic pressure. Constraints to 
colonisation may occur that allow only an inflammation tolerant microbiome in the NOD 
strain. An enterotype associated with low-grade inflammation has been described in NOD 
mice 
26
, suggesting that subclinical inflammation contributes to shaping the gut microbiota.  
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The implication of our findings is that a therapeutic strategy aimed at inducing permanent 
changes in the gut microbiota of individuals at risk of T1D would be more effective if 
initiated in early life and continued long-term. A T1D-susceptible host genetic background 
imposes a barrier to fundamentally changing the microbiota composition. Major community 
remodelling may require therapy to reverse underlying inflammation to induce long-lasting 
effects. 
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FIGURE LEGENDS 
Figure 1. Long-term cohousing of NOD and B6 mice from birth results in an altered gut 
microbiota. (a): Schematic of cohousing design. (b): sPLS-DA multivariate analysis of mice 
cohoused from weaning and control non-cohoused B6 and NOD mice (n=6-7 per group). (c): 
sPLS-DA analysis of mice cohoused from birth (n=10-11 per group). Ellipses show 95% 
confidence intervals. (d): Genera with differential abundance in cohoused NOD vs control 
NOD mice from (c) (adj P < 0.05). CoH@W NOD: Cohoused at weaning. NCoH NOD  Not 
cohoused (control). SCoH NOD: short-term cohoused. LCoH NOD: long-term cohoused. 
Mean and SD are shown. Each experiment was performed once. 
 
Figure 2. The effect of cohousing on diabetes frequency and insulitis. Diabetes frequency 
in (a) NOD mice not cohoused (NCoH, n=23) or cohoused from weaning (CoH@W NOD 
n=22) and (b) in control NOD mice (NCoH, n=20), NOD mice cohoused from birth short-
term (SCoH n=20) or long-term cohoused (LCoH n=34). P-values from a log-rank test are 
shown. Insulitis scoring from individual mice (c) and mean insulitis scores (d) from mice 
cohoused continually from birth at 12-weeks of age. Mean and SEM are shown. Each 
experiment was performed once. 
 
Figure 3. Intestinal architecture, inflammation, goblet cell mucous production and 
lysozyme production were not altered by cohousing NOD mice. Histological sections 
from NOD mice cohoused long-term from birth (LCoH), not-cohoused NOD (NCoH) and B6 
mice culled at 12-weeks of age were scored (maximum possible score 29) (a): Examples of 
H&E stained colonic tissue and ileum Paneth structures with summary of gut scoring from 
n=6-8 mice per group. (b): Goblet PAS staining of goblet cells from colonic tissue and 
quantification of goblet cell area from n=6-8 mice per group. (c): IHC staining of lysozyme P 
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production by Paneth cells from the ileum and quantification of staining intensity in n=6-7 
mice per group. Experiment was performed once. 
 
Figure 4. Immune regulation was not restored by cohousing NOD and B6 mice. NOD 
mice cohoused long-term from birth (LCoH), not-cohoused NOD (NCoH) and B6 mice 
culled at 12-weeks of age and lymph node and spleen tissue analysed by FACS. (a): 
Foxp3+CD4+ Treg frequency within CD4+ T cells. (b): IGRP-specific and (d) insulin-
specific tetramer+ cell proportion within CD8+ T cells. Dotted line: mean frequency of 
control LLO-specific tetramer+ cells. Mean and SD are shown. LCOH: long-cohoused. 
Experiment was performed once. 
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